Status:

COMPLETED

Deprescribing Tamsulosin in Older Men

Lead Sponsor:

University of California, San Francisco

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Benign Prostatic Hyperplasia

Lower Urinary Tract Symptoms

Eligibility:

MALE

55-80 years

Phase:

PHASE4

Brief Summary

This is a pilot 12-week randomized, placebo-controlled N-of-1 deprescribing trial among older men receiving chronic tamsulosin therapy for lower urinary tract symptoms attributed to benign prostatic h...

Detailed Description

The investigators will instruct participants to monitor and record their daily urinary symptoms and medication side effects through Redcap surveys, accessible via smartphone. Medication adherence, glo...

Eligibility Criteria

Inclusion

  • Urology patient at UCSF
  • Must own Android or iPhone smartphone, tablet, or computer
  • Taking tamsulosin for urinary-related symptoms
  • Able to speak and read English
  • Male 55-80 years old of age at telephone screening.
  • Written informed consent (and assent when applicable) obtained from subject or subject' s legal representative and ability for subject to comply with the requirements of the study.
  • Willing to receive electronic PERSONAL daily intake surveys for 3 months
  • Willing to self-report urinary symptom or medication side effect data at specified frequency.
  • Have home WiFi access.
  • Patients with h/o prostate cancer may be enrolled but is not required
  • Patients with h/o kidney stones may be enrolled but is not required

Exclusion

  • Taking tamsulosin for \<12 months.
  • International Prostate Symptom Score \<5 or \>25
  • Current participation in any other mobile app-based clinical study.
  • Planning to relocate from area within the study duration.
  • Impaired vision that could limit the use of the mobile apps (participant-reported)

Key Trial Info

Start Date :

September 18 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 22 2022

Estimated Enrollment :

31 Patients enrolled

Trial Details

Trial ID

NCT05415748

Start Date

September 18 2021

End Date

July 22 2022

Last Update

August 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of California, San Francisco

San Francisco, California, United States, 94143